Product Images Zyprexa
View Photos of Packaging, Labels & Appearance
- PACKAGE LABEL - ZYPREXA 10 mg tablet, bottle of 30 - zyprexa 10mg contain 30 059 00
- PACKAGE LABEL - ZYPREXA 15 mg tablet, bottle of 30 - zyprexa 15mg contain 30 060 00
- PACKAGE LABEL - ZYPREXA 20 mg tablet, bottle of 30, trade - zyprexa 20mg contain 30 061 00
- PACKAGE LABEL - ZYPREXA 2.5 mg tablet, bottle of 30 - zyprexa 2point5mg contain 30 056 00
- PACKAGE LABEL - ZYPREXA 5 mg tablet, bottle of 30 - zyprexa 5mg contain 30 057 00
- PACKAGE LABEL - ZYPREXA 7.5 mg tablet, bottle of 30 - zyprexa 7point5mg contain 30 058 00
- Chemical Structure - zyprexa f001 v1
- zyprexa im 10mg carton 213215 v2
- PACKAGE LABEL - ZYPREXA ZYDIS 10 mg tablet, 30 sachets - zyprexa zydis 10mg carton 30 019 00
- PACKAGE LABEL - ZYPREXA ZYDIS 15 mg tablet, 30 sachets - zyprexa zydis 15mg carton 30 020 00
- PACKAGE LABEL - ZYPREXA ZYDIS 20 mg tablet, 30 sachets, trade - zyprexa zydis 20mg carton 30 021 00
- PACKAGE LABEL - ZYPREXA ZYDIS 5 mg tablet, 30 sachets - zyprexa zydis 5mg carton 30 018 00
Product Label Images
The following 12 images provide visual information about the product associated with Zyprexa NDC 0002-4420 by Eli Lilly And Company, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
PACKAGE LABEL - ZYPREXA 10 mg tablet, bottle of 30 - zyprexa 10mg contain 30 059 00
PACKAGE LABEL - ZYPREXA 15 mg tablet, bottle of 30 - zyprexa 15mg contain 30 060 00
PACKAGE LABEL - ZYPREXA 20 mg tablet, bottle of 30, trade - zyprexa 20mg contain 30 061 00
PACKAGE LABEL - ZYPREXA 2.5 mg tablet, bottle of 30 - zyprexa 2point5mg contain 30 056 00
PACKAGE LABEL - ZYPREXA 5 mg tablet, bottle of 30 - zyprexa 5mg contain 30 057 00
PACKAGE LABEL - ZYPREXA 7.5 mg tablet, bottle of 30 - zyprexa 7point5mg contain 30 058 00
Chemical Structure - zyprexa f001 v1
zyprexa im 10mg carton 213215 v2
This is a description of an intramuscular injection drug called Dlanzapie. Each single-dose vial contains 10 mg of the active ingredient. The product from Eland has been marketed by Lily USA, LLC. The instructions for dosage, reconstitution, and administration can be found in the accompanying literature. Upon reconstitution with sterile water for injection, 2.1 mL will contain 5 mg of Dlanzapie. The product should be used intramuscularly only, and the solution should appear clear and yellow. Store at a controlled room temperature of 20° to 25°C before reconstitution, and use immediately or discard any unused portion within 1 hour after reconstitution. Protect from light. There is no information about the uses of the drug or its side effects.*
PACKAGE LABEL - ZYPREXA ZYDIS 10 mg tablet, 30 sachets - zyprexa zydis 10mg carton 30 019 00
PACKAGE LABEL - ZYPREXA ZYDIS 15 mg tablet, 30 sachets - zyprexa zydis 15mg carton 30 020 00
PACKAGE LABEL - ZYPREXA ZYDIS 20 mg tablet, 30 sachets, trade - zyprexa zydis 20mg carton 30 021 00
PACKAGE LABEL - ZYPREXA ZYDIS 5 mg tablet, 30 sachets - zyprexa zydis 5mg carton 30 018 00
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.
